In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.

Inspired by advances in cancer therapy, a team at the Buck Institute has engineered immune cells equipped with specialized ...

FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.

Researchers at the University of Texas at Dallas, led by bioengineering associate professor Dr. Girgis Obaid, are partnering ...

A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for ...

A doctor breaks down metastatic renal cell carcinoma, explaining how the cancer spreads and discussing emerging treatment ...

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths ...

At the cutting edge of TIL therapy development, Creative Biolabs offers end-to-end and integrated solutions dedicated to the unique needs of this dis ...

Unfortunately, they can't usually cure the cancer. Whether you have targeted therapy or immunotherapy depends on: genetic changes in the cancer cells how far the cancer has grown (the stage) other ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...